Mount Sinai enrolling patients in DoD-funded trial of neuromodulation therapy for postpartum depression

Summary

Mount Sinai is enrolling patients in a Department of Defense-funded clinical trial of a drug-free neuromodulation therapy for postpartum depression, targeting military families and veterans for whom pharmacological treatment during the postnatal period raises concerns about medication effects on breastfeeding infants. The DoD's interest in postpartum depression reflects the high prevalence in military families and the unique constraints that limit pharmacological treatment in this population.